
Please try another search
RAPT Therapeutics, Inc. operates as a clinical-stage immunology-based biopharmaceutical company that focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. The company’s lead inflammation drug candidate is zelnecirnon (RPT193), a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Its lead oncology drug candidate is tivumecirnon (FLX475), an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is based in South San Francisco, California.
Name | Age | Since | Title |
---|---|---|---|
Brian Russell Wong | 53 | 2015 | CEO, President & Director |
Linda M. Kozick | 67 | 2016 | Independent Director |
Philip D. Greenberg | - | 2017 | Member of Scientific Advisory Board |
Lori M. Lyons-Williams | 48 | 2021 | Independent Chairman of the Board |
Robert Zamboni | - | - | Member of Scientific Advisory Board |
Scott Joseph Antonia | - | 2017 | Member of Scientific Advisory Board |
Andrew Mark Pardoll | - | 2017 | Member of Scientific Advisory Board |
Alexander Rudensky | - | - | Chairman of Scientific Advisory Board |
Michael F. Giordano | 67 | 2018 | Independent Director |
Emma Guttman-Yassky | - | 2019 | Member of Scientific Advisory Board |
Mary Ann Gray | 72 | 2019 | Independent Director |
Lawrence Fong | - | 2020 | Member of Scientific Advisory Board |
Lisa Beck | - | - | Member of Scientific Advisory Board |
Scott N. Braunstein | 62 | 2025 | Director |
Ashley Ledbetter Dombkowski | 54 | 2025 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review